Clinical, Diagnostic Biomarkers, Preclinical
Identification of prodromal, shared and discriminatory features in multiple system atrophy (MSA)
Henry Houlden, MD, PhD
UCL
learning center
Projects Funded
Mission MSA actively seeks out novel ideas and innovative approaches to address critical questions related to MSA diagnosis, treatment, and patient care. The Seed Grant Research Program invites professionals from around the world to apply for research funding for pathogenesis, biomarker, preclinical, and clinical studies. Explore the research grants funded in our most recent cycle below.
Â
Your journey into the heart of MSA research begins here. Together, we are leading the charge to cure Multiple System Atrophy.
Clinical, Diagnostic Biomarkers, Pathogenesis, Preclinical
Development of non-human primate MSA model and imaging biomarker of mitochondrial activity in MSA
Norihito Uemura, MD, PhD,
Kyoto University Hospital
Clinical, Pathogenesis
Detection of somatic single nucleotide variants and other small mutations in alpha-synuclein in multiple system atrophy brain
Christos Proukakis, PhD, FRCP,
University College London
Clinical, Diagnostic Biomarkers, Pathogenesis
Investigation of inflammatory triggers and antigen-specific immunity in multiple system atrophy subtypes
Wouter Peelaerts, PhD,
KU Leuven
Clinical, Diagnostic Biomarkers
Refining the clinical diagnosis of MSA-C and MSA-P using olfactory mucosa and skin samples
Fabio Moda, PhD,
Fondazione IRCCS Istituto Neurologico Carlo Besta
Clinical, Diagnostic Biomarkers
Validating differential diagnosis power of oxidative stress modulating plasma EV proteins from MSA patients: Paving ways to clinical application
Shau-Ping Lin, PhD, National Taiwan University